MAP3K6 Activators
MAP3K6 Activators encompass a range of chemical compounds that directly or indirectly boost the functional activity of MAP3K6 through specific signaling cascades. Forskolin, by raising levels of intracellular cyclic AMP (cAMP), indirectly promotes MAP3K6's activation via cAMP-dependent protein kinase A (PKA), which can phosphorylate various substrates including kinases upstream of MAP3K6. Similarly, Sphingosine-1-phosphate, through its action on G protein-coupled receptors, may amplify signaling processes that culminate in MAP3K6 activation. Ionomycin acts as a calcium ionophore, augmenting intracellular calcium levels that can activate calmodulin-dependent kinases, which might in turn phosphorylate and activate MAP3K6.
Furthermore, Epigallocatechin gallate, by inhibiting certain kinases, could alleviate inhibitory controls on MAP3K6, paving the way for its activation. Phorbol esters like PMA stimulate protein kinase C (PKC), which has the potential to phosphorylate MAP3K6, leading to its activation. LY294002, by modulating PI3K and MEK1/2 respectively, may indirectly foster an environment conducive to MAP3K6 activation by shifting the balance of cellular signaling. Anisomycin, a MAPK pathway activator, can also influence the cellular signaling milieu in a manner that might support MAP3K6 activation. Okadaic Acid, Thapsigargin, and Dibutyryl-cAMP round out this array of activators, working through the inhibition of phosphatases and the disruption of calcium signaling or by serving as a cAMP analog to stimulate PKA, respectively, thereby promoting the activation of MAP3K6.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP, which can activate PKA. PKA can then phosphorylate MAP3K6, leading to its activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Activates G protein-coupled receptors, potentially enhancing pathways that include MAP3K6 activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits certain kinases, potentially reducing negative regulation on MAP3K6 and fostering its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, which can activate calmodulin-dependent kinases that may phosphorylate and activate MAP3K6. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can phosphorylate and activate MAP3K6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, altering signaling pathways and potentially relieving inhibition of MAP3K6. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates MAPK pathways, which could lead to subsequent activation of MAP3K6. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, causing increased phosphorylation and potential activation of MAP3K6. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis and could enhance the activity of calcium-dependent kinases that activate MAP3K6. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can activate PKA, leading to potential activation of MAP3K6 through phosphorylation. | ||||||